| Completed | Effect of a Concurrent Physical Exercise Program in Hemodialysis Patients NCT06664385 | Pedro Julian Flores Moreno | N/A |
| Completed | A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP NCT06362759 | Tourmaline Bio, Inc. | Phase 2 |
| Completed | Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal F NCT05735951 | Biocodex | Phase 1 |
| Completed | Exploring the Impact of " ACP Board Game for Life" on Death Preparation and Anxiety in Patients With Stage 4 a NCT06046261 | National Cheng-Kung University Hospital | N/A |
| Completed | 2D-speckle Tracking in Pediatric Renal Chronic Disease NCT04897672 | University Hospital, Montpellier | — |
| Completed | The Efficacy of VR and AR on Pruritus NCT04289038 | Hacettepe University | N/A |
| Completed | Apixaban in Subjects With Peritoneal Dialysis NCT04006093 | University Hospital, Caen | Phase 1 |
| Recruiting | Kidney Precision Medicine Project NCT04334707 | Icahn School of Medicine at Mount Sinai | — |
| Terminated | Anti-inflammatory Cells in Peritoneal Cavity NCT03189316 | University Hospital, Montpellier | N/A |
| Unknown | Creation and Validation of a Questionnaire to Measure the Feelings of a Chronic Renal Insufficiency Person Dur NCT02791828 | CHU de Reims | — |
| Completed | VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC NCT02685995 | University of Pennsylvania | N/A |
| Unknown | Bone and Cardiovascular Disease After Kidney Transplant NCT02751099 | Centro Hospitalar de Lisboa Central | — |
| Unknown | Neuromuscular Electrical Stimulation During Hemodialysis in Peripheral Muscle Strength and Exercise Capacity NCT02786849 | University of the State of Santa Catarina | N/A |
| Unknown | Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota NCT02302287 | Azienda Sanitaria ASL Avellino 2 | Phase 4 |
| Completed | Social Determinants in Chronic Disease in British Columbia NCT02203084 | University of British Columbia | — |
| Completed | Treatment of Masked Hypertension NCT02142881 | University of Minnesota | Phase 3 |
| Unknown | Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease NCT02002585 | Charles University, Czech Republic | Phase 2 |
| Completed | Exercise and Vascular Function in Chronic Kidney Disease NCT02050035 | University of Delaware | Phase 4 |
| Completed | An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects NCT01846468 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease NCT02433925 | Universidade Federal Fluminense | Phase 3 |
| Completed | Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol NCT02474810 | Nova Scotia Health Authority | N/A |
| Completed | Investigations of the Optimum Serum Bicarbonate Level in Renal Disease. NCT01574157 | VA Office of Research and Development | N/A |
| Unknown | Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency NCT02147782 | Shanghai University of Traditional Chinese Medicine | — |
| Unknown | Genetic Predictors of Renal Dysfunction Following Heart Transplantation NCT01686191 | University of Colorado, Denver | — |
| Completed | Renal Transplantation and Raltegravir in HIV-Infected Patients NCT01453192 | ANRS, Emerging Infectious Diseases | Phase 3 |
| Completed | A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009) NCT01407276 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Endotoxin, Neutrophil Function and Albumin in Renal Insufficiency NCT01362569 | Vanessa Stadlbauer-Koellner, MD | — |
| Completed | Improving Evidence-Based Primary Care for Chronic Kidney Disease NCT01767883 | American Academy of Family Physicians | N/A |
| Completed | Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated NCT01327924 | Novo Nordisk A/S | — |
| Completed | Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents NCT01245374 | Novo Nordisk A/S | Phase 4 |
| Completed | Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary NCT01252810 | GE Healthcare | Phase 2 |
| Unknown | Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation NCT00890253 | Armin Goralczyk | Phase 2 |
| Completed | The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease NCT01029002 | Albert Einstein College of Medicine | Phase 3 |
| Completed | Vitamin D and Chronic Renal Insufficiency NCT00968877 | Odense University Hospital | Phase 3 |
| Completed | Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study NCT00921687 | Louis Stokes VA Medical Center | N/A |
| Completed | Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic K NCT00888069 | OPKO IP Holdings II, Inc. | Phase 1 |
| Withdrawn | Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Ass NCT00869856 | Sandoz | Phase 3 |
| Completed | Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromid NCT00823628 | Seoul National University Bundang Hospital | Phase 4 |
| Completed | Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Se NCT00792857 | OPKO IP Holdings II, Inc. | Phase 1 |
| Completed | Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease NCT00742716 | OPKO IP Holdings II, Inc. | Phase 2 |
| Completed | Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal F NCT00716573 | Hospices Civils de Lyon | Phase 4 |
| Terminated | Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE) NCT01225458 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in Morbimortality NCT00684034 | Assistance Publique Hopitaux De Marseille | N/A |
| Unknown | Inspiratory Muscle Training in Patients With End Stage Renal Failure NCT01347775 | The University of Queensland | Phase 4 |
| Terminated | Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Sub NCT00701714 | Sandoz | Phase 3 |
| Withdrawn | Fall Prevention by Alfacalcidol and Training NCT00483275 | Ruhr University of Bochum | Phase 4 |
| Completed | N-acetyl-cysteine (NAC) and Kidney Graft Function NCT00998972 | Institut d'Anesthesiologie des Alpes Maritimes | Phase 3 |
| Completed | Observational Prospective Study on Patients Treated With Norditropin® NCT00960128 | Novo Nordisk A/S | — |
| Completed | Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodia NCT00268957 | Genzyme, a Sanofi Company | Phase 3 |
| Completed | Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Sec NCT00123461 | Genzyme, a Sanofi Company | Phase 4 |
| Unknown | Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study NCT00323713 | Azienda Sanitaria ASL Avellino 2 | N/A |
| Completed | An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(C NCT00095056 | Merck Sharp & Dohme LLC | Phase 3 |
| Terminated | A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease. NCT00495365 | Ortho Biotech Products, L.P. | Phase 4 |
| Completed | MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application NCT00223548 | University of Ulm | Phase 2 |
| Completed | Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients NCT00042432 | Amgen | Phase 2 |
| Completed | STAAR-3 Clinical Study NCT00369733 | Amgen | Phase 4 |
| Completed | A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (E NCT00097617 | Genentech, Inc. | — |
| Completed | STAAR-1 Clinical Study NCT00369772 | Amgen | Phase 4 |
| Completed | A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chro NCT00307814 | Ortho Biotech Products, L.P. | Phase 2 |
| Completed | STAAR-2 Clinical Study NCT00368901 | Amgen | Phase 4 |
| Completed | Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retard NCT00184769 | Novo Nordisk A/S | Phase 4 |
| Suspended | Effect of Cytokines on Growth of Children With Chronic Kidney Failure NCT00194883 | Weill Medical College of Cornell University | Phase 4 |
| Completed | African American Study of Kidney Disease and Hypertension NCT04364139 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |